Invention Application
- Patent Title: GLUCOPYRANOSYL DERIVATIVE AND USE THEREOF
-
Application No.: US16960488Application Date: 2019-01-22
-
Publication No.: US20210061839A1Publication Date: 2021-03-04
- Inventor: Zheng GU , Wuyong WU , Tong QU , Panpan KANG , Zongyuan ZHANG , Weiming HUANG , Jianyu LIU , Yingjun ZHANG
- Applicant: SUNSHINE LAKE PHARMA CO., LTD.
- Applicant Address: CN Dongguan, Guangdong
- Assignee: SUNSHINE LAKE PHARMA CO., LTD.
- Current Assignee: SUNSHINE LAKE PHARMA CO., LTD.
- Current Assignee Address: CN Dongguan, Guangdong
- Priority: CN201810063061.0 20180123
- International Application: PCT/CN2019/072666 WO 20190122
- Main IPC: C07H15/207
- IPC: C07H15/207
Abstract:
A glucopyranosyl derivative as a sodium-dependent glucose transporters inhibitor, especially as a SGLT1 inhibitor, a pharmaceutically acceptable salt or a stereoisomer thereof, a pharmaceutical composition thereof, and the uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.
Public/Granted literature
- US11084842B2 Glucopyranosyl derivative and use thereof Public/Granted day:2021-08-10
Information query
